1528.HK
1528.HK
CNE100001ZS2
RS MACALLINE
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 35/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Largely moves in line with the broader market.

Beta (Market Relation)
1.14x
Above average
Volatility (5Y p.a.)
53.6% p.a.
5-Year Horizon
Max Drawdown (5Y)
-79.2%
5-Year Horizon
Sharpe Ratio
-0.52
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Volatility Expansion (3Y > 5Y) High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -24.8%
3 Years 57.6% -63.4% -0.48 -25.4%
5 Years 53.6% -79.2% -0.52 -25.5%
10 Years 44.6% -92.2% -0.45 -17.4%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Elevated Short-Term Volatility: 3Y volatility (57.6%) is noticeably higher than the 5Y average (53.6%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (53.6% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -92.2% in the extended horizon.
ende